Stockchase Opinions

Jeff Parent B. Eng. FCSI CIM AEterna Zentaris Inc. AEZS-T SELL Jan 26, 2012

Rather bad couple of days. Was down substantially, outside of a range. Consolidated. It broke down and is more likely to go down. $1.50 on the downside.
$1.640

Stock price when the opinion was issued

biotechnology pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

BUY ON WEAKNESS
Would like to get in at the $6 level. Cash flow positive.
TOP PICK
His stock filter picked stocks on a momentum basis and where money was flowing into them. The low it hit recently is a meaningful low. Likes the sector and feels it has been oversold. Do not let it violate the March low.